174 results on '"Burke, John"'
Search Results
2. Meta-analysis of SATB2 immunohistochemical expression in colorectal cancer versus primary ovarian mucinous neoplasms
3. Acute Macrocystic Thoracic Schwannoma: Systematic Review and Illustrative Case Example
4. Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL
5. Lateral Meniscal Oblique Radial Tears Were Observed Concomitantly With Anterior Cruciate Ligament Tears in 6% of Pediatric Patients Undergoing Anterior Cruciate Ligament Reconstruction
6. Toxoplasma gondii mitochondrial association factor 1b interactome reveals novel binding partners including Ral GTPase accelerating protein α1
7. Cost of Disease Progression in Diffuse Large B-Cell Lymphoma After Frontline Treatment With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
8. Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study
9. Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma
10. Molecular basis for differential activation of p101 and p84 complexes of PI3Kγ by Ras and GPCRs
11. Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination
12. Total Hip Arthroplasty in Patients Who Have Respiratory Disease Who use Supplemental Home Oxygen
13. Molecular basis for the recruitment of the Rab effector protein WDR44 by the GTPase Rab11
14. Osteopetrosis is Associated With an Increased Risk for Intraoperative Periprosthetic Fracture in Total Hip Arthroplasty but not in Total Knee Arthroplasty
15. Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy
16. Use of Supplemental Home Oxygen is Associated With Early Postoperative Complications Following Total Knee Arthroplasty
17. Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma
18. The Utilization of Postoperative Inpatient Ultrasound for Lower Extremity Deep Venous Thrombosis Following Total Hip Arthroplasty has Decreased Dramatically Over the Past Decade With No Obvious Negative Impact on Patient Care
19. Transanal minimally invasive surgery (TAMIS) for rectal cancer
20. Inferior Clinical Outcomes for Patients with Medicaid Insurance After Surgery for Degenerative Lumbar Spondylolisthesis: A Prospective Registry Analysis of 608 Patients
21. SOHO State of the Art Updates and Next Questions | Management of Most Difficult Cases of Chronic Lymphocytic Leukemia: Relapse After Both BTK and BCL2 Inhibition and Richter Transformation
22. Improvements in Health-related Quality of Life and Symptoms in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Final Results From the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine
23. Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies
24. In vitro reconstitution of Sgk3 activation by phosphatidylinositol 3-phosphate
25. The Natural History of Spinal Cord Injury
26. Evaluating the Clinical Utility and Cost of Imaging Strategies in Adults with Newly Diagnosed Primary Intradural Spinal Tumors
27. Fibrinolytic therapy for refractory COVID‐19 acute respiratory distress syndrome: Scientific rationale and review
28. Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL Study
29. Symptom Burden and Blood Counts in Patients With Polycythemia Vera in the United States: An Analysis From the REVEAL Study
30. ABCL-272 A Phase 2, Open-Label Study of Loncastuximab Tesirine in Combination With Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Patients With Diffuse Large B-Cell Lymphoma (LOTIS-9)
31. ABCL-102 A SEER-Medicare Analysis of the Cost of Disease Progression After Frontline R-CHOP in Diffuse Large B-Cell Lymphoma
32. ABCL-101 Cost-Effectiveness of Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
33. ABCL-073 Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results From the Phase III POLARIX Study
34. ABCL-051 realMIND: A Prospective, Multicenter, Observational Study of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Starting Second/Third-Line Therapy and Not Receiving a Stem Cell Transplant
35. ABCL-023 frontMIND: A Phase III, Randomized, Double-Blind Study of Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP Alone for Newly Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma
36. HL-444 An Oncology Simulation Model to Estimate 10-Year Overall Survival, Progression-Free Survival, and Stem Cell Transplantation for Frontline, Stage III or IV Classic Hodgkin Lymphoma Based on the Overall Survival Update of the ECHELON-1 Trial: A United States Perspective
37. MPN-103 A Real-World Evaluation of the Association Between Elevated Blood Counts and Thrombotic Events in Polycythemia Vera: Analysis of Data From the REVEAL Study
38. An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma
39. Predictors of 30-Day Outcomes in Octogenarians with Traumatic C2 Fractures Undergoing Surgery
40. The Endoscopic Buccal Fat Pad Flap for Closure of Skull Base Defects: A Report of 5 Cases
41. The Accuracy of Multimodality Intraoperative Neuromonitoring to Predict Postoperative Neurologic Deficits Following Cervical Laminoplasty
42. Bone Morphogenic Protein Use in Spinal Surgery
43. Stimulation of the human medial temporal lobe between learning and recall selectively enhances forgetting
44. Isolated inferior oblique myectomy for vertical deviations of at least 20 prism diopters in the primary position
45. Differences in Quality of Life Between Bendamustine-Rituximab and R-CHOP/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
46. The importance of research during pharmacy residency training
47. Transanal minimally invasive surgery (TAMIS): Pros and cons of this evolving procedure
48. Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study
49. Cobalt(III)hexaammine-dependent photocrosslinks in the hairpin ribozyme
50. A Real-World Evaluation of Risk Factors for Disease Progression in Patients With Polycythemia Vera (PV): An Analysis From the Prospective Observational Study of Patients With Polycythemia Vera in US Clinical Practices (REVEAL)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.